{"id":"https://openalex.org/W2531633101","doi":"https://doi.org/10.1016/s2055-6640(20)31150-x","title":"HIV\u20131 resistance to dolutegravir: update and new insights","display_name":"HIV\u20131 resistance to dolutegravir: update and new insights","publication_year":2015,"publication_date":"2015-01-01","ids":{"openalex":"https://openalex.org/W2531633101","doi":"https://doi.org/10.1016/s2055-6640(20)31150-x","mag":"2531633101","pmid":"https://pubmed.ncbi.nlm.nih.gov/27482391","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4946665"},"language":"en","primary_location":{"id":"doi:10.1016/s2055-6640(20)31150-x","doi":"https://doi.org/10.1016/s2055-6640(20)31150-x","is_oa":true,"landing_page_url":"https://doi.org/10.1016/s2055-6640(20)31150-x","pdf_url":"https://www.sciencedirect.com/science/article/pii/S205566402031150X/pdf","source":{"id":"https://openalex.org/S2764990692","display_name":"Journal of Virus Eradication","issn_l":"2055-6640","issn":["2055-6640","2055-6659"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","poland-20","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Virus Eradication","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.sciencedirect.com/science/article/pii/S205566402031150X/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5029881635","display_name":"Mark A. Wainberg","orcid":"https://orcid.org/0000-0002-0272-1317","observed_orcids":["https://orcid.org/0000-0002-0272-1317"]},"institutions":[{"id":"https://openalex.org/I2801824472","display_name":"Jewish General Hospital","ror":"https://ror.org/056jjra10","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2801824472","https://openalex.org/I2801902503","https://openalex.org/I4210139015","https://openalex.org/I4405256057","https://openalex.org/I4405279980"]},{"id":"https://openalex.org/I4405267356","display_name":"Lady Davis Institute for Medical Research","ror":"https://ror.org/02c1np254","country_code":"CA","type":"education","lineage":["https://openalex.org/I2801824472","https://openalex.org/I2801902503","https://openalex.org/I4210139015","https://openalex.org/I4405256057","https://openalex.org/I4405267356","https://openalex.org/I4405279980"]},{"id":"https://openalex.org/I5023651","display_name":"McGill University","ror":"https://ror.org/01pxwe438","country_code":"CA","type":"education","lineage":["https://openalex.org/I5023651"]}],"countries":["CA"],"is_corresponding":true,"raw_author_name":"Mark A. Wainberg","raw_affiliation_strings":["McGill University AIDS Centre, Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"McGill University AIDS Centre, Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada","institution_ids":["https://openalex.org/I2801824472","https://openalex.org/I4405267356","https://openalex.org/I5023651"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5087129093","display_name":"Ying-Shan Han","orcid":"https://orcid.org/0000-0002-0307-0843","observed_orcids":["https://orcid.org/0000-0002-0307-0843"]},"institutions":[{"id":"https://openalex.org/I2801824472","display_name":"Jewish General Hospital","ror":"https://ror.org/056jjra10","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2801824472","https://openalex.org/I2801902503","https://openalex.org/I4210139015","https://openalex.org/I4405256057","https://openalex.org/I4405279980"]},{"id":"https://openalex.org/I4405267356","display_name":"Lady Davis Institute for Medical Research","ror":"https://ror.org/02c1np254","country_code":"CA","type":"education","lineage":["https://openalex.org/I2801824472","https://openalex.org/I2801902503","https://openalex.org/I4210139015","https://openalex.org/I4405256057","https://openalex.org/I4405267356","https://openalex.org/I4405279980"]},{"id":"https://openalex.org/I5023651","display_name":"McGill University","ror":"https://ror.org/01pxwe438","country_code":"CA","type":"education","lineage":["https://openalex.org/I5023651"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Ying-Shan Han","raw_affiliation_strings":["McGill University AIDS Centre, Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"McGill University AIDS Centre, Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada","institution_ids":["https://openalex.org/I2801824472","https://openalex.org/I4405267356","https://openalex.org/I5023651"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5029881635"],"corresponding_institution_ids":["https://openalex.org/I2801824472","https://openalex.org/I4405267356","https://openalex.org/I5023651"],"apc_list":{"value":2950,"currency":"USD","value_usd":2950},"apc_paid":{"value":2950,"currency":"USD","value_usd":2950},"fwci":1.2978,"has_fulltext":true,"cited_by_count":16,"citation_normalized_percentile":{"value":0.81664113,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":97},"biblio":{"volume":"1","issue":"1","first_page":"13","last_page":"16"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10147","display_name":"Antibiotic Resistance in Bacteria","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1313","display_name":"Molecular Medicine"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hiv-1","display_name":"HIV-1","score":0.9660000205039978},{"id":"https://openalex.org/keywords/dolutegravir","display_name":"dolutegravir","score":0.9940000176429749},{"id":"https://openalex.org/keywords/integrase-strand-transfer-inhibitors","display_name":"integrase strand transfer inhibitors","score":0.9390000104904175},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.8600000143051147},{"id":"https://openalex.org/keywords/resistance-mutations","display_name":"resistance mutations","score":0.9120000004768372},{"id":"https://openalex.org/keywords/cross-resistance","display_name":"cross-resistance","score":0.9049999713897705},{"id":"https://openalex.org/keywords/raltegravir","display_name":"raltegravir","score":0.9940000176429749},{"id":"https://openalex.org/keywords/elvitegravir","display_name":"elvitegravir","score":1.0},{"id":"https://openalex.org/keywords/first-line-antiretroviral-therapy","display_name":"first-line antiretroviral therapy","score":0.8650000095367432},{"id":"https://openalex.org/keywords/resistance-mechanisms","display_name":"resistance mechanisms","score":0.6790000200271606}],"concepts":[{"id":"https://openalex.org/C2779502633","wikidata":"https://www.wikidata.org/wiki/Q937224","display_name":"Dolutegravir","level":5,"score":0.9877740144729614},{"id":"https://openalex.org/C2777068322","wikidata":"https://www.wikidata.org/wiki/Q2740966","display_name":"Elvitegravir","level":5,"score":0.9733716249465942},{"id":"https://openalex.org/C2780404665","wikidata":"https://www.wikidata.org/wiki/Q421552","display_name":"Raltegravir","level":5,"score":0.9189913272857666},{"id":"https://openalex.org/C114851261","wikidata":"https://www.wikidata.org/wiki/Q12147416","display_name":"Drug resistance","level":2,"score":0.5770983099937439},{"id":"https://openalex.org/C14430832","wikidata":"https://www.wikidata.org/wiki/Q412550","display_name":"Integrase","level":3,"score":0.5749938488006592},{"id":"https://openalex.org/C2777302000","wikidata":"https://www.wikidata.org/wiki/Q412251","display_name":"Integrase inhibitor","level":5,"score":0.531303882598877},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5088491439819336},{"id":"https://openalex.org/C2778080818","wikidata":"https://www.wikidata.org/wiki/Q1788422","display_name":"Cross-resistance","level":2,"score":0.4901924729347229},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.48397135734558105},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.47246766090393066},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.45407000184059143},{"id":"https://openalex.org/C3018890749","wikidata":"https://www.wikidata.org/wiki/Q204711","display_name":"Food and drug administration","level":2,"score":0.42883968353271484},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3246641159057617},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.23881065845489502},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.21795687079429626},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.09465983510017395}],"mesh":[],"locations_count":5,"locations":[{"id":"doi:10.1016/s2055-6640(20)31150-x","doi":"https://doi.org/10.1016/s2055-6640(20)31150-x","is_oa":true,"landing_page_url":"https://doi.org/10.1016/s2055-6640(20)31150-x","pdf_url":"https://www.sciencedirect.com/science/article/pii/S205566402031150X/pdf","source":{"id":"https://openalex.org/S2764990692","display_name":"Journal of Virus Eradication","issn_l":"2055-6640","issn":["2055-6640","2055-6659"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","poland-20","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Virus Eradication","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:3931334","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4946665","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:4946665","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4946665","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Virus Erad","raw_type":"Text"},{"id":"pmid:27482391","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/27482391","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of virus eradication","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:f38777e814404a9cac2a4f453dfe5cbb","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/f38777e814404a9cac2a4f453dfe5cbb","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal of Virus Eradication, Vol 1, Iss 1, Pp 13-16 (2015)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1016/s2055-6640(20)31150-x","doi":"https://doi.org/10.1016/s2055-6640(20)31150-x","is_oa":true,"landing_page_url":"https://doi.org/10.1016/s2055-6640(20)31150-x","pdf_url":"https://www.sciencedirect.com/science/article/pii/S205566402031150X/pdf","source":{"id":"https://openalex.org/S2764990692","display_name":"Journal of Virus Eradication","issn_l":"2055-6640","issn":["2055-6640","2055-6659"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","poland-20","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Virus Eradication","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2531633101.pdf","grobid_xml":"https://content.openalex.org/works/W2531633101.grobid-xml"},"referenced_works_count":23,"referenced_works":["https://openalex.org/W1966567607","https://openalex.org/W1973819232","https://openalex.org/W2022787293","https://openalex.org/W2055829400","https://openalex.org/W2056002345","https://openalex.org/W2057925552","https://openalex.org/W2062514953","https://openalex.org/W2066141181","https://openalex.org/W2066315689","https://openalex.org/W2066583628","https://openalex.org/W2086617757","https://openalex.org/W2099408735","https://openalex.org/W2110471430","https://openalex.org/W2113248560","https://openalex.org/W2113596204","https://openalex.org/W2117383437","https://openalex.org/W2119506500","https://openalex.org/W2124631799","https://openalex.org/W2132585743","https://openalex.org/W2144255757","https://openalex.org/W2152880150","https://openalex.org/W2166733691","https://openalex.org/W6677091722"],"related_works":["https://openalex.org/W2094303174","https://openalex.org/W4309572164","https://openalex.org/W2415914350","https://openalex.org/W2795173636","https://openalex.org/W2013498624","https://openalex.org/W2622470207","https://openalex.org/W3155554351","https://openalex.org/W2085405111","https://openalex.org/W3082751997","https://openalex.org/W2810322166"],"abstract_inverted_index":{"Integrase":[0],"strand":[1],"transfer":[2],"inhibitors":[3],"(INSTIs)":[4],"are":[5],"the":[6,20,106,113],"latest":[7],"class":[8],"of":[9,98,108],"potent":[10],"anti-HIV":[11],"drugs.":[12],"Currently,":[13],"three":[14],"INSTIs":[15],"have":[16],"been":[17,48,55,84,116],"approved":[18],"by":[19],"US":[21],"Food":[22],"and":[23,30,37,41,62,64,103],"Drug":[24],"Administration:":[25],"raltegravir":[26],"(RAL),":[27],"elvitegravir":[28],"(EVG)":[29],"dolutegravir":[31],"(DTG).":[32],"Resistance":[33],"mutations":[34,73,111],"to":[35,70,95,101],"RAL":[36,63],"EVG":[38,65],"emerge":[39],"rapidly,":[40],"significant":[42],"cross-resistance":[43,53],"between":[44],"these":[45],"compounds":[46],"has":[47,54,81,115],"documented.":[49],"In":[50],"addition,":[51],"limited":[52],"observed":[56],"among":[57],"DTG,":[58,71,96,102],"a":[59],"newer":[60],"INSTI,":[61],"even":[66],"though":[67],"clinical":[68],"resistance":[69,77,94,100,110],"or":[72],"associated":[74],"with":[75],"DTG":[76],"in":[78,90,118],"treatment-na\u00efve":[79],"patients,":[80],"not":[82],"yet":[83],"observed.":[85],"This":[86],"review":[87],"summarises":[88],"progress":[89],"studies":[91],"on":[92],"understanding":[93],"mechanisms":[97],"possible":[99],"reasons":[104],"for":[105],"absence":[107],"DTG-associated":[109],"when":[112],"drug":[114],"used":[117],"first-line":[119],"therapy.":[120]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":3},{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":3},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":2}],"updated_date":"2026-10-28T10:33:24.094632","created_date":"2016-10-21T00:00:00"}